These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21769869)

  • 1. Branched-chain amino acids prevent insulin-induced hepatic tumor cell proliferation by inducing apoptosis through mTORC1 and mTORC2-dependent mechanisms.
    Hagiwara A; Nishiyama M; Ishizaki S
    J Cell Physiol; 2012 May; 227(5):2097-105. PubMed ID: 21769869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells.
    Ninomiya S; Shimizu M; Imai K; Takai K; Shiraki M; Hara T; Tsurumi H; Ishizaki S; Moriwaki H
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2092-100. PubMed ID: 21952585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
    Terakura D; Shimizu M; Iwasa J; Baba A; Kochi T; Ohno T; Kubota M; Shirakami Y; Shiraki M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
    Carcinogenesis; 2012 Dec; 33(12):2499-506. PubMed ID: 23027617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched chain amino acid suppressed insulin-initiated proliferation of human cancer cells through induction of autophagy.
    Wubetu GY; Utsunomiya T; Ishikawa D; Ikemoto T; Yamada S; Morine Y; Iwahashi S; Saito Y; Arakawa Y; Imura S; Arimochi H; Shimada M
    Anticancer Res; 2014 Sep; 34(9):4789-96. PubMed ID: 25202059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.
    Takegoshi K; Honda M; Okada H; Takabatake R; Matsuzawa-Nagata N; Campbell JS; Nishikawa M; Shimakami T; Shirasaki T; Sakai Y; Yamashita T; Takamura T; Tanaka T; Kaneko S
    Oncotarget; 2017 Mar; 8(11):18191-18205. PubMed ID: 28212548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and mTORC2 signaling pathways.
    Chen XG; Liu F; Song XF; Wang ZH; Dong ZQ; Hu ZQ; Lan RZ; Guan W; Zhou TG; Xu XM; Lei H; Ye ZQ; Peng EJ; Du LH; Zhuang QY
    Mol Carcinog; 2010 Jun; 49(6):603-10. PubMed ID: 20512842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periexercise coingestion of branched-chain amino acids and carbohydrate in men does not preferentially augment resistance exercise-induced increases in phosphatidylinositol 3 kinase/protein kinase B-mammalian target of rapamycin pathway markers indicative of muscle protein synthesis.
    Ferreira MP; Li R; Cooke M; Kreider RB; Willoughby DS
    Nutr Res; 2014 Mar; 34(3):191-8. PubMed ID: 24655485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
    Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
    EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-Chain Amino Acids Exacerbate Obesity-Related Hepatic Glucose and Lipid Metabolic Disorders via Attenuating Akt2 Signaling.
    Zhao H; Zhang F; Sun D; Wang X; Zhang X; Zhang J; Yan F; Huang C; Xie H; Lin C; Liu Y; Fan M; Yan W; Chen Y; Lian K; Li Y; Zhang L; Wang S; Tao L
    Diabetes; 2020 Jun; 69(6):1164-1177. PubMed ID: 32184272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease.
    Kuwahata M; Kubota H; Kanouchi H; Ito S; Ogawa A; Kobayashi Y; Kido Y
    Nutr Res; 2012 Jul; 32(7):522-9. PubMed ID: 22901560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.
    Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells.
    Miuma S; Ichikawa T; Arima K; Takeshita S; Muraoka T; Matsuzaki T; Ootani M; Shibata H; Akiyama M; Ozawa E; Miyaaki H; Taura N; Takeshima F; Nakao K
    J Cell Biochem; 2012 Oct; 113(10):3113-21. PubMed ID: 22581719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
    Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branch chain amino acid, insulin, and hepatic tumor cell proliferation.
    Wiwanitkit V
    J Cell Physiol; 2012 Jul; 227(7):2971. PubMed ID: 22021055
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells.
    Wang J; Xiao X; Zhang Y; Shi D; Chen W; Fu L; Liu L; Xie F; Kang T; Huang W; Deng W
    J Pineal Res; 2012 Aug; 53(1):77-90. PubMed ID: 22335196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis.
    Evert M; Calvisi DF; Evert K; De Murtas V; Gasparetti G; Mattu S; Destefanis G; Ladu S; Zimmermann A; Delogu S; Thiel S; Thiele A; Ribback S; Dombrowski F
    Hepatology; 2012 May; 55(5):1473-84. PubMed ID: 22271091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms of DHEA and DHEAs on apoptosis and cell cycle arrest via Akt pathway in hepatoma cell lines].
    Jiang YF; Zhao PW; Tan Y; Liu LH; Li MH; Matsuzaki Y; Niu JQ
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):441-4. PubMed ID: 17594810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease.
    Kawaguchi T; Nagao Y; Matsuoka H; Ide T; Sata M
    Int J Mol Med; 2008 Jul; 22(1):105-12. PubMed ID: 18575782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
    Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
    Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.